Ameriprise Financial updates stress test figures, shares tracked against U.S. peers

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 10:59.

Ameriprise Financial (US03076C1062) sits in focus this weekend as investors digest the latest Federal Reserve stress test round for large U.S. financial institutions and assess capital return capacity compared with peers such as Morgan Stanley and Goldman Sachs. The group’s New York Stock Exchange listing ties it directly into the broader S&P 500 financials discussion, where buyback and dividend potential remains a central theme.

How Ameriprise compares after Fed tests

The Federal Reserve published its 2026 Dodd-Frank Act stress test results for major U.S. banks and bank holding companies, outlining post-stress capital ratios and loss assumptions across the sector. Although Ameriprise is smaller than the largest money-center banks, its wealth and asset management focus means investors often benchmark it against diversified players like Morgan Stanley when evaluating resilience and capital flexibility.

In the latest cycle, the Fed highlighted that aggregate large-bank capital remained comfortably above minimum requirements even under a severe global downturn scenario, reinforcing the sector’s ability to sustain dividends and, in many cases, continue share repurchases. Market commentary from Reuters and other outlets emphasizes that investors now turn to company-specific capital plans, which will be disclosed in detail by individual institutions after internal board approvals.

Analyst views and valuation backdrop

Sell-side coverage on Ameriprise in recent months has generally framed the stock as a high-return wealth manager leveraged to fee-based advisory and asset management, with sensitivity to equity markets via assets under management and administration. Consensus data compiled by MarketScreener shows that a majority of analysts rate Ameriprise shares at Buy or equivalent, with price targets typically referencing mid- to high-teens forward earnings multiples relative to the U.S. financials peer group.

Commentary from U.S. brokerages over the past quarter has highlighted Ameriprise’s strong return on equity and consistent capital return track record through dividends and buybacks, albeit with exposure to market volatility that can affect fee revenues and client activity. Against this backdrop, investors use the Fed stress test cycle as an additional check on the robustness of capital levels and potential regulatory constraints on future payout decisions for the broader sector.

How Ameriprise earns its money

Ameriprise Financial generates the bulk of its revenue from advice and wealth management, including financial planning, brokerage, and managed accounts for retail and affluent clients, complemented by asset management under the Columbia Threadneedle Investments brand. Additional income streams come from retirement and protection products such as annuities and insurance, which add interest and spread-based earnings alongside fee revenue.

Where the shares trade today

Ameriprise Financial shares (US03076C1062) most recently traded on the NYSE at around the mid-300 dollar range, with pricing data referenced as of late June 2026 in U.S. dollars based on consolidated exchange information.

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. Investors should conduct their own research or consult a qualified advisor before making investment decisions.